HOPKINTON, Mass., April 4 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. today announced that the Wellcome Trust Sanger Institute has purchased the microfluidic-based LabChip(R) 90 Automated Electrophoresis System to quality control DNA and protein within its Atlas of Protein Expression project. The goal of the project is to systematically study the way proteins are “expressed,” or produced, in cells and tissues and to create a quality, information-rich database of protein expression profiles accessible to the worldwide research community.
The Sanger Institute uses Caliper’s LabChip 90 system to generate quantitative sizing, concentration, and purity data for polymerase chain reaction (PCR) products, expressed proteins, and the antibodies used for immunohistochemistry experiments. The ability to machine microfluidic chips that are inherently more reproducible than traditional slab gels, combined with the fact that the LabChip 90 system generates real-time electronic data suitable for inter-laboratory data sharing, makes the system a good match for the project’s goals. The system also allows researchers to process multiple experiments at the same time and generate multiple data views.
“We are consistently looking for tools that can save time and redundancy in our research process,” said Michael Dyson, project leader, Wellcome Trust Sanger Institute. “For this leading-edge project, we need to deploy and integrate systems that reduce intensity of human effort and provide high quality data.”
“The Sanger Institute’s use of the LabChip 90 system is an ideal example of how our microfluidic and automation technologies are bringing value to high-throughput, collaborative experimentation,” said Kevin Hrusovsky, president and chief executive officer of Caliper Life Sciences. “We believe this kind of collaborative academic research will remain essential to the advancement of life science research, and we are excited to be contributing innovative tools and technologies to the process.”
About Wellcome Trust Sanger Institute
The Wellcome Trust Sanger Institute was founded in 1992 as a focus for UK sequencing efforts. The Institute is responsible for the completion of approximately one-third of the human genome as well as genomes of model organisms and more than 90 pathogen genomes.
About Caliper Life Sciences
Caliper Life Sciences is a leading provider of drug discovery and life sciences research solutions for the pharmaceutical and biotechnology industries. Caliper’s mission is to transform drug discovery and diagnostics by offering the industry’s most comprehensive array of products and services for clinically relevant experimentation. Based in Hopkinton, Massachusetts, Caliper services approximately 80 percent of the world’s leading pharmaceutical companies through representation in 30 countries. More information about Caliper and its products and services can be found on the web at www.caliperLS.com.
NOTE: LabChip and Caliper are registered trademarks of Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc.
CONTACT: Michele Boudreau, Corporate Communications, +1-650-279-2088, forCaliper Life Sciences; or Tania Stockbridge for Schwartz Communications,+1-781-684-0770, or caliper@schwartz-pr.com, for Caliper Life Sciences
Web site: http://www.caliperLS.com/
